drugset / Trial / NCT05553782
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Phase 0
Recruiting
30 enrolled
Brigham and Women's Hospital
Adenoid Cystic Carcinoma Research Foundation · collab
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying the effect of different drugs as possible treatments for salivary and other head and neck cancers/ The name of the study intervention involved in this study is: \-- implantable microdevice
Timeline
- Start
- 2023-11-01
- Primary completion
- 2029-04-01
- Completion
- 2029-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | — | — |
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Lenvatinib | Small molecule | — | — |
| Subject | Pembrolizumab | Monoclonal antibody | — | — |
| Subject | Tretinoin | Unknown | — | — |
| Subject | Venetoclax | Small molecule | — | — |
| Subject | Vinorelbine | Small molecule | — | — |